Ocular Therapeutix plans wet AMD drug filing in Q4 2026

Markets Investing.com By Investing.com 17 Jun 2026 12:53 1 min read

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.